Global Non Invasive Glucose Meter Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 165.41 Million |
 Market Size (Forecast Year) |
USD 321.22 Million |
 CAGR |
% |
| Major Markets Players |
Global Non-Invasive Glucose Meter Market, By Component Outlook (Measuring Device, Transmitter and Software/ App), Site Outlook (Arm/ Wrist, Ear Lobe, Forefinger and Thumb and Cornea/ Eye), Application Outlook (Intensive Insulin Therapy, Hypoglycemia and Diabetic Foot Ulcer Tracking), End-User Outlook (Home Healthcare Setting, Healthcare Provider and Research Institutes) – Industry Trends and Forecast to 2030.
Non-Invasive Glucose Meter Market Analysis and Size
According to the World Health Organization (WHO), there are currently approximately 450 million cases of diabetes worldwide, with a potential increase to 700 million by 2045, with an increase to 39.7 million by 2030 and 60.6 million by 2060 in the United States alone. More than 90% of diabetics are type 2, and the International Diabetes Federation predicts that the proportion of the world's population affected by diabetes will rise sharply, as will the number of diabetics.
Data Bridge Market Research analyses that the non-invasive glucose meter market, which was USD 165.41 million in 2022, is expected to reach USD 321.22 million by 2030, at a CAGR of 8.65% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Non-Invasive Glucose Meter Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015 - 2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Component Outlook (Measuring Device, Transmitter and Software/ App), Site Outlook (Arm/ Wrist, Ear Lobe, Forefinger and Thumb and Cornea/ Eye), Application Outlook (Intensive Insulin Therapy, Hypoglycemia and Diabetic Foot Ulcer Tracking), End-User Outlook (Home Healthcare Setting, Healthcare Provider and Research Institutes) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Abbott (U.S.), PHC Holdings Corporation (Japan), WellDoc, Inc (India), Sanofi (France), Dexcom, Inc (U.S.), DarioHealth Corp. (U.S.), Medtronic (Ireland), B. Braun SE (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Insulet Corporation (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Tidepool (U.S.), Medtronic (Ireland), Tandem Diabetes Care (U.S.), LifeScan (U.S.), AgaMatrix (U.S.), Glooko Inc. (U.S.), DarioHealth (Israel), B.D. (U.S.) |
|
Market Opportunities |
|
Market Definition
Non-Invasive Glucose Meters measure the amount of glucose in the blood. In the case of diabetic patients, glucose level information is critical. Glucose monitoring provides information for diabetic management and the effect of diabetic medication on the glucose level, allowing you to determine whether your blood glucose level is high or low.
Global Non-Invasive Glucose Meter Market Dynamics
Drivers
- Technological advancements will bolster the growth
Emerging technologies in smart insulin pens are expected to drive the global non-invasive glucose meter market during the forecast period. The iSenz adaptor for smart insulin pens is used to detect insulin levels. It provides injection angles for diabetic injection site optimization. Easylog is an adaptor for insulin pens that are linked to the internet. It gives patients the proper dosage and improved comfort to manage chronic illnesses such as diabetes. InsulCheck is a cap that fits insulin pens and includes a sensor to monitor temperature and consumption. And these are just a few examples of smart insulin pens accelerating market growth.
- Integration of monitoring and therapeutic features
Smart insulin pens have numerous advantages for diabetes management. These pens have extra features that make remembering the last insulin dose easier. Daily insulin injections with a syringe and needle are difficult and unpleasant. More people are using their smartphones and the internet to track records because of advancements in device communication technology which drives the market growth.
Opportunities
- Integration of data analytics and artificial intelligence
Big data analytics and AI are revolutionizing digital diabetes management. The market is expected to grow exponentially as new efficient digital diabetes management technologies become available, allowing for better diabetes control. With the increased use and growth of big data analytics, healthcare professionals and patients will have access to real-time structured and unstructured data.
Furthermore, AI-powered digital diabetes management devices aid in providing tailored hypoglycemic control solutions to patients. The device was designed to offer patients personalized insights into the glucose level response based on food intake, insulin dosage, and daily routines. As a result, introducing such novel and promising technologies in the field of non-invasive glucose meters will boost the market growth.
Restraints/Challenges
- Risks associated with non-invasive blood glucose monitoring devices
Non-invasive blood glucose monitoring devices are the next step in continuous glucose monitoring (CGM) devices for a variety of reasons, including wearer comfort, which is a challenging factor for the non-invasive glucose metre market. However, disease-free glucose monitoring devices are based on a variety of technologies that detect biological features of the skin or organic fluids. The accuracy provided by these product types does not come close to that of CGM devices under uncontrolled conditions, which is a restraint on the growth of the non-invasive glucose metre market globally during the forecast period.
This non-invasive glucose meter market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the non-invasive glucose meter market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Non-Invasive Glucose Meter Market
The COVID-19 pandemic has accelerated the growth of the non-invasive glucose metre market. Blood glucose control became critical for patients admitted to hospitals with severe lung infections. The medications used to treat the disease caused a significant change in the patient's blood glucose levels. Furthermore, people with diabetes who were diagnosed with COVID-19 were admitted to critical care, according to the Centers for Disease Control and Prevention. As a result, the demand for non-invasive glucose metres has rise steeply.
Recent developments
- In March 2022, Dexcom Inc. announced that the FDA had granted Dexcom continuous glucose monitor (CGM) use in hospitals Breakthrough Device Designation. This cutting-edge compact device consists of a small wearable sensor and transmitter that provides real-time glucose readings, warnings, and alarms to detect potentially low or high glucose levels.
Global Non-Invasive Glucose Meter Market Scope
The non-invasive glucose meter market is segmented on the basis of component, site, application, and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Component
- Measuring Device
- Monitoring patches
- Continuous monitoring sensors
- Smart lenses
- Smart watches
- Transmitter and Software/ App
Site
- Arm/ Wrist
- Ear Lobe
- Forefinger and Thumb and Cornea/ Eye
Application
- Intensive Insulin Therapy
- Hypoglycemia and Diabetic Foot Ulcer Tracking
End-User
- Home Healthcare Setting
- Healthcare Provider
- Research Institutes
Non-Invasive Glucose Meter Market Regional Analysis/Insights
The non-invasive glucose meter market is analysed and market size insights and trends are provided by country, component, site, application, and end use as referenced above.
The countries covered in the non-invasive glucose meter market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the non-invasive glucose meter market because of the increased healthcare spending.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of increased glucose monitoring penetration, increased patient awareness, and rising per capita healthcare expenditure in this region
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The non-invasive glucose meter market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for non-invasive glucose meter market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the non-invasive glucose meter market. The data is available for historic period 2011-2021.
Competitive Landscape and Non-Invasive Glucose Meter Market Share Analysis
The non-invasive glucose meter market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to non-invasive glucose meter market.
Some of the major players operating in the non-invasive glucose meter market are:
- Abbott (U.S.)
- PHC Holdings Corporation (Japan)
- WellDoc, Inc (India)
- Sanofi (France)
- Dexcom, Inc (U.S.)
- DarioHealth Corp. (U.S.)
- Medtronic (Ireland)
- B. Braun SE (Germany)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Insulet Corporation (U.S.)
- Ascensia Diabetes Care Holdings AG (Switzerland)
- Tidepool (U.S.)
- Medtronic (Ireland)
- Tandem Diabetes Care (U.S.)
- LifeScan (U.S.)
- AgaMatrix (U.S.)
- Glooko Inc. (U.S.)
- DarioHealth (Israel)
- B.D. (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
